A Phase II Clinical Trial to Evaluate the Efficacy and Safety of GZR18 Injection in Chinese Patients With Type 2 Diabetes Mellitus
Conditions: Type 2 Diabetes Interventions: Drug: GZR18; Drug: Semaglutide Sponsors: Gan and Lee Pharmaceuticals, USA Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: China Health | Clinical Trials | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Research